Breaking News
Get 40% Off 0
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2? Unlock full list
Close

Mankind Pharma Ltd (MNKI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,321.10 -47.65    -2.01%
05:59:55 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE634S01028 
S/N:  MANKIND
  • Volume: 255,775
  • Bid/Ask: 2,315.65 / 2,321.00
  • Day's Range: 2,310.00 - 2,350.00
Mankind Pharma 2,321.10 -47.65 -2.01%

MNKI Income Statement

 
Featured here, the Income Statement (earnings report) for Mankind Pharma Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 26069.59 27080.99 25786.18 20526.67
Revenue 26069.59 27080.99 25786.18 20526.67
Other Revenue, Total - - - -
Cost of Revenue, Total 8275.89 8248.6 8199.58 7007.67
Gross Profit 17793.7 18832.39 17586.6 13519
Total Operating Expenses 21101.79 21219.38 20111.57 17471.78
Selling/General/Admin. Expenses, Total 5683.53 5719.59 5529.1 5709.66
Research & Development - - - 62.95
Depreciation / Amortization - - - 3259.2
Interest Expense (Income) - Net Operating -91.85 -86.24 -63.4 -23.93
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 7234.23 7337.43 6446.28 4715.43
Operating Income 4967.8 5861.62 5674.61 3054.89
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - 226.99
Other, Net -655.5 -548.26 -570.05 -944.97
Net Income Before Taxes 5623.29 6409.87 6244.66 3772.87
Provision for Income Taxes 1025.16 1298.1 1302.77 835.87
Net Income After Taxes 4598.14 5111.77 4941.88 2937
Minority Interest - 2051.4 - 1880.7
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 4537.6 5010.26 4868.72 2854.42
Total Extraordinary Items - - - -
Net Income 4537.6 5010.26 4868.72 2854.42
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 4537.6 5010.26 4868.72 2854.42
Dilution Adjustment - - - -1.87
Diluted Net Income 4537.6 5010.26 4868.72 2856.29
Diluted Weighted Average Shares 401.2 401.14 401.05 400.33
Diluted EPS Excluding Extraordinary Items 11.31 12.49 12.14 7.13
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 8.61 9.73 9.55 5.41
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MNKI Comments

Write your thoughts about Mankind Pharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rawan Kumar
Rawan Kumar May 14, 2023 12:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tomorrow us confirm
Sanjay Gupta
Sanjay Gupta May 09, 2023 11:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
feeling sorry now for exiting too early.. 😭😭
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email